Phone: +39-051-6366757
E-mail address: michela.pasello@ior.it
Phone: +39-051-6366757
E-mail address: michela.pasello@ior.it
MSc, PhD
Staff Researcher
2000: Degree in Biological Sciences at the University of Ferrara, Italy.
2007: PhD in Oncology and Experimental Pathology at the University “Alma Mater Studiorum” of Bologna, Italy.
2001: Formal ability to exert the profession of Biologist.
Competences
Principal methods of cellular biology (eukaryotic and prokaryotic cells), biomelocular biology and methods for the evaluation of drugs citotossicity. 3D colture. Recombinant DNA technology and DNA cloning. Recombinant protein production. “Antibody phage display” method.
Computer skills
Excellent knowledge of computer tools for PC and Mac.
Expert processing and image analysis, expert management of spreadsheets. Expert management of databases.
Tutoring of graduating students.
Collaborator in the following research projects
Since 2003, Collaborator of Research Projects funded by AIRC, the Ministry of Health (Current and Finalized Research), the Emilia-Romagna Region and the European Union.
Co-Author of: 38 publications in international journals, 1 book chapter and 1 editorial.
https://www.ncbi.nlm.nih.gov/myncbi/michela.pasello.1/bibliography/public/
SCOPUS ID: 6507813614
ORCID ID: 0000-0002-2020-9376
Research ID: C-7156-2019
H-index Scopus: 22
Guest Associate Editor for Frontiers in Endocrinology – Bone research. Active member of FOSTER consortium (Fight Osteosarcoma Through European Research).
Members of scientific associations:
Preclinical characterization of bone sarcoma models (cell lines, primary cultures, and PDX) in order to identify: i) biomarkers of possible prognostic importance, ii) novel therapeutic targets, and iii) the genetic and molecular basis responsible for drug resistance.
Isolation of monoclonal antibodies for clinical uses (therapeutic and/or diagnostic) by using different methods (hybridoma and screening of phagic libraries). Development of anti-CD99 antibodies for diagnostic and therapeutic options.